• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性血栓栓塞性肺动脉高压患者行肺动脉内膜剥脱术后凝血因子 VIII 和纤维蛋白原的上调。

Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension.

机构信息

Division of Internal Medicine, Department of Internal Medicine and Rehabilitation, Helsinki University Hospital, Helsinki, Finland.

Department of Cardiac Surgery, Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

出版信息

Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231158369. doi: 10.1177/10760296231158369.

DOI:10.1177/10760296231158369
PMID:36890726
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9998419/
Abstract

OBJECTIVES

Chronic thromboembolic pulmonary hypertension (CTEPH) is associated with thrombotic states including elevated coagulation factor VIII (FVIII). Pulmonary endarterectomy (PEA) is the main treatment for CTEPH, and efficient anticoagulation is essential to prevent thromboembolism recurrence after surgery. We aimed to characterize longitudinal changes in FVIII and other coagulation biomarkers after PEA.

METHODS

Coagulation biomarker levels were measured at baseline and up to 12 months after operation in 17 consecutive patients with PEA. Temporal patterns of coagulation biomarkers, and correlation of FVIII with other coagulation biomarkers, were analyzed.

RESULTS

Baseline FVIII levels were elevated in 71% of the patients (mean 216 ± 67 IU/dl). FVIII doubled 7 days after PEA, peaking at 471 ± 87 IU/dl, and gradually returned to respective baseline levels within 3 months. Postoperative fibrinogen levels were also elevated. Antithrombin decreased at 1 to 3 days, D-dimer increased at 1 to 4 weeks, and thrombocytosis was observed at 2 weeks.

CONCLUSIONS

FVIII is elevated in most patients with CTEPH. After PEA, early but transient elevation of FVIII and fibrinogen, and delayed reactive thrombocytosis, occurs, and warrants careful postoperative anticoagulation to prevent thromboembolism recurrence.

摘要

目的

慢性血栓栓塞性肺动脉高压(CTEPH)与包括凝血因子 VIII (FVIII)升高在内的血栓形成状态有关。肺动脉内膜切除术(PEA)是 CTEPH 的主要治疗方法,有效的抗凝对于预防手术后血栓栓塞复发至关重要。我们旨在描述 PEA 后 FVIII 和其他凝血生物标志物的纵向变化。

方法

在 17 例连续接受 PEA 的患者中,在基线时和术后长达 12 个月时测量凝血生物标志物水平。分析凝血生物标志物的时间模式以及 FVIII 与其他凝血生物标志物的相关性。

结果

71%的患者基线 FVIII 水平升高(平均 216±67IU/dl)。PEA 后 7 天 FVIII 增加一倍,达到 471±87IU/dl,并在 3 个月内逐渐恢复到各自的基线水平。术后纤维蛋白原水平也升高。抗凝血酶在 1 至 3 天下降,D-二聚体在 1 至 4 周增加,2 周时出现血小板增多。

结论

大多数 CTEPH 患者的 FVIII 升高。PEA 后,早期但短暂的 FVIII 和纤维蛋白原升高,以及延迟的反应性血小板增多,需要术后仔细抗凝以预防血栓栓塞复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/9998419/fb856aeff6d8/10.1177_10760296231158369-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/9998419/362f4d5c747c/10.1177_10760296231158369-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/9998419/b4418c09c04e/10.1177_10760296231158369-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/9998419/4f5154cad3a4/10.1177_10760296231158369-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/9998419/fb856aeff6d8/10.1177_10760296231158369-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/9998419/362f4d5c747c/10.1177_10760296231158369-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/9998419/b4418c09c04e/10.1177_10760296231158369-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/9998419/4f5154cad3a4/10.1177_10760296231158369-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc54/9998419/fb856aeff6d8/10.1177_10760296231158369-fig4.jpg

相似文献

1
Upregulation of Coagulation Factor VIII and Fibrinogen After Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension.慢性血栓栓塞性肺动脉高压患者行肺动脉内膜剥脱术后凝血因子 VIII 和纤维蛋白原的上调。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231158369. doi: 10.1177/10760296231158369.
2
Pseudo Heparin Resistance After Pulmonary Endarterectomy: Role of Thrombus Production of Factor VIII.肺血管成形术后假性肝素抵抗:VIII 因子血栓生成的作用。
Semin Thorac Cardiovasc Surg. 2022 Spring;34(1):315-323. doi: 10.1053/j.semtcvs.2021.03.042. Epub 2021 May 10.
3
Coagulation-Fibrinolysis System and Postoperative Outcomes of Patients With Chronic Thromboembolic Pulmonary Hypertension.凝血-纤溶系统与慢性血栓栓塞性肺动脉高压患者的术后结局
Circ J. 2016;80(4):970-9. doi: 10.1253/circj.CJ-15-1208. Epub 2016 Feb 16.
4
Hereditary and acquired thrombotic risk factors for chronic thromboembolic pulmonary hypertension.慢性血栓栓塞性肺动脉高压的遗传性和获得性血栓形成危险因素。
Blood Coagul Fibrinolysis. 2010 Apr;21(3):201-6. doi: 10.1097/MBC.0b013e328331e664.
5
High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension.慢性血栓栓塞性肺动脉高压中凝血因子VIII升高的高患病率。
Thromb Haemost. 2003 Sep;90(3):372-6. doi: 10.1160/TH03-02-0067.
6
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study.慢性血栓栓塞性肺动脉高压:一项观察性研究。
Medicina (Kaunas). 2022 Aug 13;58(8):1094. doi: 10.3390/medicina58081094.
7
Results of one-year anticoagulation in patients with newly detected chronic thromboembolic pulmonary hypertension not treated with pulmonary endarterectomy.未接受肺动脉内膜剥脱术治疗的新诊断慢性血栓栓塞性肺动脉高压患者的一年抗凝治疗结果
Kardiol Pol. 2006 Nov;64(11):1196-202; discussion 1203-4.
8
Supervised Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension as Early Follow-Up Treatment after Pulmonary Endarterectomy: A Prospective Cohort Study.慢性血栓栓塞性肺动脉高压患者肺血管内膜剥脱术后早期随访的监督运动训练:一项前瞻性队列研究。
Respiration. 2020;99(7):577-588. doi: 10.1159/000508754. Epub 2020 Jul 29.
9
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.波生坦治疗无法手术的慢性血栓栓塞性肺动脉高压:BENEFiT(波生坦对无法手术的慢性血栓栓塞性肺动脉高压形式的影响),一项随机、安慰剂对照试验。
J Am Coll Cardiol. 2008 Dec 16;52(25):2127-34. doi: 10.1016/j.jacc.2008.08.059.
10
Early postoperative pulmonary vascular compliance predicts outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.慢性血栓栓塞性肺动脉高压患者行肺动脉内膜剥脱术后早期肺血管顺应性可预测预后。
Chest. 2011 Jul;140(1):34-41. doi: 10.1378/chest.10-1263. Epub 2010 Dec 16.

引用本文的文献

1
The Interplay Between Pulmonary Hypertension and Atrial Fibrillation: A Comprehensive Overview.肺动脉高压与心房颤动之间的相互作用:全面概述
Cells. 2025 Jun 4;14(11):839. doi: 10.3390/cells14110839.
2
Venous thromboembolism treatment failure during use of factor Xa inhibitors-association with thoracic outlet syndrome and development of chronic thromboembolic pulmonary hypertension.使用Xa因子抑制剂期间静脉血栓栓塞治疗失败——与胸廓出口综合征及慢性血栓栓塞性肺动脉高压的发生相关
Ann Med. 2024 Dec;56(1):2404549. doi: 10.1080/07853890.2024.2404549. Epub 2024 Dec 3.

本文引用的文献

1
Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension.慢性血栓栓塞性肺动脉高压中血管性血友病因子启动子的表观遗传修饰驱动血小板在肺内皮聚集。
Am J Respir Crit Care Med. 2022 Apr 1;205(7):806-818. doi: 10.1164/rccm.202109-2075OC.
2
Correlation between serum factor VIII:C levels and deep vein thrombosis following gynecological surgery.妇科手术后血清因子 VIII:C 水平与深静脉血栓形成的相关性。
Bioengineered. 2021 Dec;12(2):9668-9677. doi: 10.1080/21655979.2021.1981755.
3
Use of laboratory testing for prediction of postoperative bleeding volume in cardiovascular surgery.
实验室检测在预测心血管手术术后出血量中的应用。
Thromb J. 2021 Oct 9;19(1):70. doi: 10.1186/s12959-021-00324-4.
4
Pseudo Heparin Resistance After Pulmonary Endarterectomy: Role of Thrombus Production of Factor VIII.肺血管成形术后假性肝素抵抗:VIII 因子血栓生成的作用。
Semin Thorac Cardiovasc Surg. 2022 Spring;34(1):315-323. doi: 10.1053/j.semtcvs.2021.03.042. Epub 2021 May 10.
5
ERS statement on chronic thromboembolic pulmonary hypertension.ERS 关于慢性血栓栓塞性肺动脉高压的声明。
Eur Respir J. 2021 Jun 17;57(6). doi: 10.1183/13993003.02828-2020. Print 2021 Jun.
6
The ADAMTS13-VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension.ADAMTS13-VWF 轴在慢性血栓栓塞性肺动脉高压中失调。
Eur Respir J. 2019 Mar 28;53(3). doi: 10.1183/13993003.01805-2018. Print 2019 Mar.
7
Chronic thromboembolic pulmonary hypertension.慢性血栓栓塞性肺动脉高压。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01915-2018. Print 2019 Jan.
8
Epidemiology and risk factors for chronic thromboembolic pulmonary hypertension.慢性血栓栓塞性肺动脉高压的流行病学及危险因素
Thromb Res. 2018 Apr;164:145-149. doi: 10.1016/j.thromres.2018.01.012. Epub 2018 Jan 8.
9
Long Period and High Level of D-Dimer after Coronary Artery Bypass Grafting Surgery.冠状动脉搭桥手术后D-二聚体的长期高水平
Int Heart J. 2018 Jan 27;59(1):51-57. doi: 10.1536/ihj.16-595. Epub 2017 Dec 27.
10
Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature.急性肺栓塞后慢性血栓栓塞性肺动脉高压的发生率:已发表文献的当代观点。
Eur Respir J. 2017 Feb 23;49(2). doi: 10.1183/13993003.01792-2016. Print 2017 Feb.